These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8921435)

  • 1. The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation.
    Meyer KB; Teh YM; Neuberger MS
    Int Immunol; 1996 Oct; 8(10):1561-8. PubMed ID: 8921435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
    Roque MC; Smith PA; Blasquez VC
    Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining.
    Hiramatsu R; Akagi K; Matsuoka M; Sakumi K; Nakamura H; Kingsbury L; David C; Hardy RR; Yamamura K; Sakano H
    Cell; 1995 Dec; 83(7):1113-23. PubMed ID: 8548799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
    Zhou X; Xiang Y; Garrard WT
    J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.
    Zhou X; Xian W; Zhang J; Zhu Y; Shao X; Han Y; Qi Y; Ding X; Wang X
    Immunology; 2018 Dec; 155(4):491-498. PubMed ID: 30098214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sequences from downstream of the J kappa cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain.
    Klix N; Jolly CJ; Davies SL; Brüggemann M; Williams GT; Neuberger MS
    Eur J Immunol; 1998 Jan; 28(1):317-26. PubMed ID: 9485211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression.
    Zhou X; Xiang Y; Ding X; Garrard WT
    J Immunol; 2012 Mar; 188(6):2722-32. PubMed ID: 22323542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lineage-restricted rearrangement of a human Ig kappa transgene.
    Cavelier P; Nato F; Coquilleau I; Rolink A; Rougeon F; Goodhardt M
    Eur J Immunol; 1997 Jul; 27(7):1626-31. PubMed ID: 9247570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
    Pongubala JM; Atchison ML
    J Biol Chem; 1995 Apr; 270(17):10304-13. PubMed ID: 7730336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
    Pongubala JM; Atchison ML
    Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
    Shaffer AL; Peng A; Schlissel MS
    Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PMA/ionomycin induces Ig kappa 3' enhancer activity which is in part mediated by a unique NFAT transcription complex.
    Meyer KB; Ireland J
    Eur J Immunol; 1998 May; 28(5):1467-80. PubMed ID: 9603451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
    Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
    Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II.
    Raschke EE; Albert T; Eick D
    J Immunol; 1999 Oct; 163(8):4375-82. PubMed ID: 10510378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
    Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
    Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers.
    Goyenechea B; Klix N; Yélamos J; Williams GT; Riddell A; Neuberger MS; Milstein C
    EMBO J; 1997 Jul; 16(13):3987-94. PubMed ID: 9233808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association.
    McDevit DC; Perkins L; Atchison ML; Nikolajczyk BS
    J Immunol; 2005 Mar; 174(5):2834-42. PubMed ID: 15728493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin kappa light chain gene promoter and enhancer are not responsible for B-cell restricted gene rearrangement.
    Goodhardt M; Babinet C; Lutfalla G; Kallenbach S; Cavelier P; Rougeon F
    Nucleic Acids Res; 1989 Sep; 17(18):7403-15. PubMed ID: 2508061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.